iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Angioedema

Angioedema

Management of acute and chronic angioedema.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
DermatologyAllergyEmergency Medicine

Clinical Guidelines

CKS: Angio-oedema and anaphylaxis
National
NICE CKS: Angio-oedema and anaphylaxis
National
NICE guideline [TA606]: Lanadelumab for preventing recurrent attacks of hereditary angioedema
National
NICE guideline [TA738]: Berotralstat for preventing recurrent attacks of hereditary angioedema
National
NICE technology appraisal guidance [TA738]: Berotralstat for preventing recurrent attacks of hereditary angioedema
National

Recent iatroX Q&As

  • What are the key differences in the management of acute versus chronic angioedema in primary care?Updated: 8/17/2025
  • What are the indications for referring a patient with angioedema to a specialist?Updated: 8/17/2025
  • Which medications are commonly associated with drug-induced angioedema, and how should I manage these cases?Updated: 8/17/2025
  • What initial investigations should I consider for a patient with recurrent episodes of angioedema?Updated: 8/17/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play